Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
Nadim Hallab
Has grant
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Determination of excessive immune reactivity to real time implant debris generate
Open Date: 2017-09-30
Close Date: 2019-07-31
Grant: Close
Corrosion Induced Hip Implant Failure: Synergistic Interactions of Patient, Mater
Open Date: 2016-09-19
Close Date: 2022-08-31
Grant: Close
Inflammasome Danger Signaling:A Novel Target to Prevent Debris Induced Osteolysis
Open Date: 2012-09-17
Close Date: 2018-06-30
Grant: Close
Battlefield-Acquired Immunogenicity to Metals Affects Orthopaedic Implant Outcome
Open Date: 2010-09-30
Close Date: 2016-09-29
Grant: Close
Bioreactivity Markers in Total Hip Replacments
Open Date: 2002-03-22
Close Date: 2005-02-28
Articles (5)
Year:
2025
Year:
2025
Past evaluation of particle contamination on packaged implants has typically been conducted using US Pharmacopeia (USP) 788, a 1970s pharmaceutical guideline created to evaluate contaminant particles in injectable fluids and syringes. Our objective was to reestablish relevant acceptance criteria for residual orthopedic and other implant debris, including smaller particles (i.e., <10 μm in diameter). Packaged total hip arthroplasty (THA) titanium (Ti6Al4V)‐alloy femoral stems were used (hydroxyapatite [HA]‐coated and non‐coated stems). Short‐term ultrasonication and longer‐term 24‐hour soak/agitation methods were used to elute surface‐bound contaminant particles, and released particles were analyzed via scanning electron microscopy, energy‐dispersive x‐ray analysis, image analysis, and particle characterization. For HA‐coated THA‐stems, >99% of eluted particles were calcium phosphate. For plain non‐coated THA‐stems, >99% of eluted particles were titanium‐alloy‐based. The number‐based median size of particles in both groups was approximately 1.5 μm in diameter despite being composed of different materials. The total volume of particulate removed from HA‐coated stems was 0.037 mm 3 (671 × 10 3 particles total), which was approximately >50‐fold more volume than that on plain non‐coated stems at 0.0006 mm 3 (89 × 10 3 particles total). Only non‐coated THA stems passed reestablished USP788 acceptance criteria, compared by using equivalent total volumes of contaminant particulate within new and legacy guideline ranges of >10 and >25 μm ECD, that is, <1.0 × 10 7 particles for <1 μm diameter in size, <600,000 for <1–10 μm, <6000 for 10–25 μm and <600 for >25 μm. These results fill a knowledge gap on how much residual debris can be expected to exist on packaged implants and can be used as a basis for updating acceptance criteria (i.e., termed USP788‐Implant [USP788‐I]). Residual implant particulate assessment is critical given the increasing implant complexity and new manufacturing techniques (e.g., additive manufacturing).
Year:
2024
Year:
2024
Year:
2023
Collaborators (5)
Peter Wahl
Deputy Group Leader Biomechanics and Implant Design
University of Basel
Joshua Jacobs
Professor and Chairman
Rush University Medical Center
Robin Pourzal
Assistant Professor
Rush University Medical Center
Michael Kurtz
Drexel University
Joshua Rainey
University of Utah
Make your next move.
Prepare your application
Review drafts before you send them.